A detailed history of Morgan Stanley transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Morgan Stanley holds 153,248 shares of PYXS stock, worth $258,989. This represents 0.0% of its overall portfolio holdings.

Number of Shares
153,248
Previous 82,611 85.51%
Holding current value
$258,989
Previous $273,000 105.86%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.83 - $3.94 $199,902 - $278,309
70,637 Added 85.51%
153,248 $562,000
Q2 2024

Oct 17, 2024

BUY
$3.06 - $5.58 $119,597 - $218,088
39,084 Added 89.79%
82,611 $273,000
Q2 2024

Aug 14, 2024

BUY
$3.06 - $5.58 $119,597 - $218,088
39,084 Added 89.79%
82,611 $273,000
Q1 2024

Oct 17, 2024

SELL
$2.03 - $6.59 $79,340 - $257,563
-39,084 Reduced 47.31%
43,527 $185,000
Q1 2024

Aug 16, 2024

BUY
$2.03 - $6.59 $81,863 - $265,754
40,327 Added 1260.22%
43,527 $185,000
Q1 2024

May 15, 2024

BUY
$2.03 - $6.59 $81,863 - $265,754
40,327 Added 1260.22%
43,527 $185,000
Q4 2023

Aug 16, 2024

SELL
$1.4 - $2.09 $111,175 - $165,968
-79,411 Reduced 96.13%
3,200 $5,000
Q3 2023

Nov 15, 2023

BUY
$1.6 - $2.78 $4,320 - $7,505
2,700 Added 540.0%
3,200 $6,000
Q2 2023

Aug 14, 2023

SELL
$2.46 - $4.07 $413,466 - $684,069
-168,076 Reduced 99.7%
500 $1,000
Q1 2023

May 15, 2023

BUY
$1.38 - $6.0 $85,776 - $372,942
62,157 Added 58.41%
168,576 $675,000
Q4 2022

Feb 14, 2023

SELL
$1.14 - $2.0 $17,762 - $31,162
-15,581 Reduced 12.77%
106,419 $142,000
Q3 2022

Nov 14, 2022

SELL
$1.88 - $3.03 $27,968 - $45,077
-14,877 Reduced 10.87%
122,000 $240,000
Q2 2022

Oct 27, 2022

BUY
$2.02 - $4.53 $270,055 - $605,620
133,691 Added 4196.2%
136,877 $325,000
Q2 2022

Aug 15, 2022

BUY
$2.02 - $4.53 $270,055 - $605,620
133,691 Added 4196.2%
136,877 $325,000
Q1 2022

Oct 27, 2022

SELL
$4.04 - $11.43 $540,111 - $1.53 Million
-133,691 Reduced 97.67%
3,186 $12,000
Q1 2022

May 13, 2022

BUY
$4.04 - $11.43 $1,430 - $4,046
354 Added 12.5%
3,186 $12,000
Q4 2021

Feb 14, 2022

BUY
$8.39 - $13.64 $23,760 - $38,628
2,832 New
2,832 $31,000

Others Institutions Holding PYXS

About Pyxis Oncology, Inc.


  • Ticker PYXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,096,400
  • Market Cap $59.3M
  • Description
  • Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...
More about PYXS
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.